The ATDC Conference has been an integral part of education and case-based study of upcoming and new diabetes technology for over 30 years. This is an annual course designed to help healthcare providers caring for patients with diabetes, including but not limited to: endocrinologists/diabetes specialists, internists, pediatricians, family physicians, physician assistants, medical residents and fellows, nurse practitioners, nurses, dietitians, social workers, and Certified Diabetes Care and Education Specialists (CDCES).
Attendees will have an opportunity to interact with leaders in the field and participate in detailed question and answer sessions with the experts. The 2025 ATDC Conference will address the following needs: current therapeutic choices in treating obesity; bariatric surgery vs. pharmacotherapy; CGM use in T2D, especially in the inpatient setting and avoiding all-cause hospitalizations; challenges in managing diabetes in the primary care setting, especially when initiating CGM, pump, and hybrid closed-loop therapy (HCL); managing diabetes and creating new algorithms in HCL with AI; clinical decision support systems for patients and providers; managing diabetes during different phases of menstrual cycles and pregnancy (GDM); role of fenofibrates and mineralocorticoid receptor antagonists (MRAs) and GLP analogs in diabetic kidney disease and diabetic retinopathy; antibody screening to detect pre-diabetes (Stage 2 T1D); data integration into an EMR system and challenges; hypercortisolism in patients with diabetes; guidelines for managing T1D; alternate insulin delivery (AID) devices and their day-to-day challenges and outcomes; different glycemic metrics from CGM data and their relationship to HbA1c and eA1c vs GMI; meal specifications with AID and practical considerations while initiating different AID systems; update on SUMMIT and SURPASS CVOTs; role of GLPs in preventing the onset of T2D; and finally, we will offer an afternoon hands-on technology session to present newer devices and/or ways to use older technology more effectively. We will also host 7 keynotes across a wide range of topics over the 4-day conference.
There is a format change for 2025. We will start a full-day session on Wednesday and end with a half-day session on Saturday.
ATDC is in person only!
As one can expect from this 4-day conference, there will be enough time for attendees to interact with industry-sponsored booths and device and pharmaceutical reps.
The conference is hosted by the Barbara Davis Center for Diabetes in conjunction with the University of Colorado Denver School of Medicine. It is supported by the Children’s Diabetes Foundation and both industry sponsors and grants.
